Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Red light therapy at 655 nm significantly improved hair growth in men with hair loss.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Some people who recover from COVID-19 continue to have symptoms like fatigue and cough for over 120 days, and some experience hair loss about 59 days after getting sick.

Versican, a protein, is less present in thinning hair follicles and this decrease might contribute to common hair loss in men.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

5% minoxidil helps hair regrowth in androgenic alopecia.

Dandruff is mainly caused by a scalp reaction to yeast, can worsen hair loss, and antifungal treatments may help.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Trichoscopy is a quick, noninvasive method to diagnose hair and scalp disorders, often reducing the need for biopsies.

The conclusion is that Fgf18 and Tgf-ß signaling could be targeted for hair loss treatments.

Finding eosinophils near hair bulbs helps diagnose alopecia areata.

Cuscuta reflexa extract may help treat hair loss caused by hormones.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.